Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-10-01

Clinical Trial Update: Diaphragmatic Evaluation by Fluoroscopy to Identify Phrenic Nerve Dysfunction Related to Electroporation

View source ↗

Summary

A clinical trial investigating diaphragmatic evaluation by fluoroscopy to identify phrenic nerve dysfunction related to electroporation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Laurent Macle | Conditions: Atrial Fibrillation (AF), Phrenic Nerve-related Diaphragmatic Impairment | Status: WITHDRAWN